ERBB4 contributes to parathyroid cell dysfunction and progression of secondary hyperparathyroidism
Secondary hyperparathyroidism (SHPT) is a frequent complication of chronic kidney disease (CKD), manifested by parathyroid hyperplasia and excessive parathyroid hormone (PTH) secretion. However, the regulatory mechanisms governing SHPT progression remain incompletely understood.